Novel research is changing the way we approach healthcare for mothers and their babies. Read the feature in Northwestern Medicine magazine.
The presence of cancer cells in the bloodstream of patients with early-stage breast cancer may be predictive of benefit from radiotherapy after surgery, according to a new Northwestern Medicine study.
Drugs commonly used to prevent HIV transmission from mother to child during pregnancy were not associated with a higher risk of adverse birth outcomes, according to a new study.
A checklist intervention improved the quality of childbirth care in India, but did not lead to a reduction in the death rate of mothers and newborns, according to a new study.
The 2nd Annual Symposium on Sex Inclusion in Biomedical Research, held on the anniversary of the National Institutes of Health’s landmark sex-inclusion policy, highlighted research on sex bias in autoimmune diseases.
A combination of three therapies was found to provide the greatest benefit to patients with metastatic breast cancer classified as HER2- and hormone receptor-positive, who aren’t candidates for chemotherapy, according to a Northwestern Medicine clinical trial.
Northwestern Medicine scientists have uncovered new findings about a protein called SET1B, which could offer a novel approach to treating triple-negative breast cancer.
Women with invasive breast cancer who were treated with an aggressive lymph node removal saw no survival benefit compared to those who received a less invasive procedure, according to a new clinical trial.
Melissa Simon, MD, MPH, ’06 GME, the George H. Gardner Professor of Clinical Gynecology, will receive the 2017 Marion Spencer Fay Award in recognition of her contributions to women’s health, health equity and national health policy.